
April 10 (Reuters) - Keros Therapeutics Inc KROS.O:
KEROS THERAPEUTICS ANNOUNCES REVIEW OF STRATEGIC ALTERNATIVES
KEROS THERAPEUTICS INC - AUTHORIZED FORMATION OF COMMITTEE, CONSISTING OF INDEPENDENT AND DISINTERESTED DIRECTORS, TO OVERSEE PROCESS
KEROS THERAPEUTICS- INTENDS TO CONSIDER RANGE OF STRATEGIC ALTERNATIVES, INCLUDING BUT NOT LIMITED TO SALE
KEROS THERAPEUTICS INC - ADOPTED LIMITED-DURATION STOCKHOLDER RIGHTS PLAN